Literature DB >> 10671066

Mutations of the human tyrosinase gene associated with tyrosinase related oculocutaneous albinism (OCA1). Mutations in brief no. 204. Online.

W S Oetting1, J P Fryer, R A King.   

Abstract

Mutations in the human tyrosinase gene produce tyrosinase-related oculocutaneous albinism (OCA1, MIM #203100). Tyrosinase is a copper containing enzyme and is responsible for catalyzing the rate limiting step in melanin biosynthesis, the hydroxylation of tyrosine to dopaquinone. We report 13 new mutations in the tyrosinase gene associated with OCA1A (without pigment) and OCA1B (with pigment) including 9 missense mutations (H19Q, R521, R77C, G97R, C289R, L312V, P313R, F340L and H404P), two nonsense mutations (W80X and R116X) and two frameshift mutations (53delG and 223 delG). Our previous work has defined clusters of missense mutations that appear to represent functional domains of the enzyme, and three of the missense mutations fall into these clusters including two (F340L and H404P) that flank the copper B bindng site and the missense mutation R52I that is located in the amino terminal end cluster of the protein. The G97R missense mutation is the first identified within the epidermal growth factor (EGF)-like sequence and the H19Q missense mutation alters the cleavage site of the signal peptide sequence. Mutational analysis can provide a definitive diagnosis of the type of OCA as well as help structure/function analysis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10671066     DOI: 10.1002/(SICI)1098-1004(1998)12:6<433::AID-HUMU14>3.0.CO;2-G

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  5 in total

1.  Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4.

Authors:  J M Newton; O Cohen-Barak; N Hagiwara; J M Gardner; M T Davisson; R A King; M H Brilliant
Journal:  Am J Hum Genet       Date:  2001-09-26       Impact factor: 11.025

2.  Oxidation of nitroxyl anion to nitric oxide by copper ions.

Authors:  S Nelli; M Hillen; K Buyukafsar; W Martin
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Molecular and clinical characterization of albinism in a large cohort of Italian patients.

Authors:  Annagiusi Gargiulo; Francesco Testa; Settimio Rossi; Valentina Di Iorio; Simona Fecarotta; Teresa de Berardinis; Antonello Iovine; Adriano Magli; Sabrina Signorini; Elisa Fazzi; Maria Silvana Galantuomo; Maurizio Fossarello; Sandro Montefusco; Alfredo Ciccodicola; Alberto Neri; Claudio Macaluso; Francesca Simonelli; Enrico Maria Surace
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-14       Impact factor: 4.799

4.  Molecular analysis of Korean patients with oculocutaneous albinism.

Authors:  Shin Hae Park; Hyojin Chae; Yonggoo Kim; Myungshin Kim
Journal:  Jpn J Ophthalmol       Date:  2011-11-01       Impact factor: 2.447

5.  Genetic analyses of Vietnamese patients with oculocutaneous albinism.

Authors:  Ma Thi Huyen Thuong; Luong Thi Lan Anh; Vu Phuong Nhung; Tran Thi Bich Ngoc; Hoang Thu Lan; Doan Kim Phuong; Nguyen Hai Ha; Nong Van Hai; Nguyen Dang Ton
Journal:  J Clin Lab Anal       Date:  2022-07-23       Impact factor: 3.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.